Thank you for registering: AcceleDent® – Amplify clinical confidence and predictability in aligner therapy.
This webinar was recorded on Friday, October 18, 2019 at 9 a.m. Pacific Time! Enjoy the recording below.
Adult orthodontic patients define themselves mainly through aesthetic needs in the visible anterior region and less through functional requirements. This also means that the patient’s expectations are increasingly similar to those of a consumer. As a result, time has thus become an important commodity in our society which we can no longer ignore in our professional efforts as orthodontists. AcceleDent enables Dr. Warshawsky to treat all kinds of complex situations in his aligner cases without compromises in biomechanics and predictability in tooth movement. His patients change aligners every 7 days, although in some cases even faster while also achieving very predictable outcomes. We will be exploring this and more in this presentation.
Here’s more information on the webinar sponsor, OrthoAccel® Technologies:
OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company’s innovations is AcceleDent, an FDA-cleared class II medical device, with CE Mark approval, that increases the predictability of clinical outcomes, helping clinicians gain more control and deliver predictable results, even with challenging tooth movements. AcceleDent has been clinically shown to accelerate tooth movement by up to 50%, while also significantly reducing the pain and discomfort associated with treatment by up to 71%, helping patients to become more compliant. OrthoAccel has received positive feedback from patients and leading orthodontists from around the world who recommend the award-winning AcceleDent to accelerate orthodontic treatment and provide more predictable orthodontic outcomes. OrthoAccel is based in Houston, Texas and operates globally in over 40 countries.